Full Text View
Tabular View
No Study Results Posted
Related Studies
Saw Palmetto Extract in Benign Prostatic Hyperplasia
This study has been completed.
Study NCT00037154   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received: May 16, 2002   Last Updated: May 3, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Benign Prostatic Hyperplasia
Additional conditions recognized in this trial
Hyperplasia
Prostatic Hyperplasia
More general conditions related to this trial
Genital Diseases, Male
Pathologic Processes
Prostatic Diseases
Interventions listed in this trial
Saw Palmetto
Additional drug interventions recognized in this trial
Permixon
More general drug interventions related to this trial
Androgen Antagonists
Estrogen Antagonists
Estrogen Receptor Modulators
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Center for Complementary and Alternative Medicine (NCCAM)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services